← FDA Drug Approvals (Drugs@FDA)

REPAGLINIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: KENTON · Approved 2015-04-24

Drug application

FDA Application #

ANDA091517

Application type

Abbreviated New Drug Application (Generic)

Brand name

REPAGLINIDE

Generic name

Repaglinide

Active ingredients

REPAGLINIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

KENTON

First approval

2015-04-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown